Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 2Pain, Intractable 1Mucositis 1Leukemia 1Inflammatory Bowel Diseases 1Diverticulitis 1Diverticular Diseases 1Colonic Neoplasms 1Cancer Pain 1Breast Neoplasms 1Breast Cancer Female 1Breakthrough Pain 1Bone Marrow Failure Disorders 1Bites and Stings 1Anemia, Aplastic 1Agnosia 1Acute Pain 1

Interventions

Trastuzumab 594Paclitaxel 561Cyclophosphamide 545Docetaxel 478Capecitabine 387Letrozole 350Fulvestrant 310Doxorubicin 285Carboplatin 277Tamoxifen 257Anastrozole 219exemestane 211Epirubicin 210Radiotherapy 197Bevacizumab 189pertuzumab 175Gemcitabine 163Vinorelbine 162pembrolizumab 161Lapatinib 161palbociclib 152Exercise 132Fluorouracil 118Albumin-Bound Paclitaxel 116eribulin 108Magnetic Resonance Spectroscopy 108130-nm albumin-bound paclitaxel 107Everolimus 103Taxes 96Cisplatin 92

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Breast Neoplasms × Passive Cutaneous Anaphylaxis × Clear all
NCT04726878 2021-11-09

ESP in Breast Surgery Due to Cancer

Medical University of Lublin

Phase 4 Completed
75 enrolled
Breast

Breast Neoplasms, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡